Literature DB >> 17553876

The amino terminus of varicella-zoster virus (VZV) glycoprotein E is required for binding to insulin-degrading enzyme, a VZV receptor.

Qingxue Li1, Tammy Krogmann, Mir A Ali, Wei-Jen Tang, Jeffrey I Cohen.   

Abstract

Varicella-zoster virus (VZV) glycoprotein E (gE) is required for VZV infection. Although gE is well conserved among alphaherpesviruses, the amino terminus of VZV gE is unique. Previously, we showed that gE interacts with insulin-degrading enzyme (IDE) and facilitates VZV infection and cell-to-cell spread of the virus. Here we define the region of VZV gE required to bind IDE. Deletion of amino acids 32 to 71 of gE, located immediately after the predicted signal peptide, resulted in loss of the ability of gE to bind IDE. A synthetic peptide corresponding to amino acids 24 to 50 of gE blocked its interaction with IDE in a concentration-dependent manner. However, a chimeric gE in which amino acids 1 to 71 of VZV gE were fused to amino acids 30 to 545 of herpes simplex virus type 2 gE did not show an increased level of binding to IDE compared with that of full-length HSV gE. Thus, amino acids 24 to 71 of gE are required for IDE binding, and the secondary structure of gE is critical for the interaction. VZV gE also forms a heterodimer with glycoprotein gI. Deletion of amino acids 163 to 208 of gE severely reduced its ability to form a complex with gI. The amino portion of IDE, as well an IDE mutant in the catalytic domain of the protein, bound to gE. Therefore, distinct motifs of VZV gE are important for binding to IDE or to gI.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17553876      PMCID: PMC1951364          DOI: 10.1128/JVI.00286-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  47 in total

1.  An N-terminal domain of herpes simplex virus type Ig E is capable of forming stable complexes with gI.

Authors:  S M Rizvi; M Raghavan
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

2.  Herpes simplex virus glycoprotein D bound to the human receptor HveA.

Authors:  A Carfí; S H Willis; J C Whitbeck; C Krummenacher; G H Cohen; R J Eisenberg; D C Wiley
Journal:  Mol Cell       Date:  2001-07       Impact factor: 17.970

3.  Functional human insulin-degrading enzyme can be expressed in bacteria.

Authors:  V Chesneau; M R Rosner
Journal:  Protein Expr Purif       Date:  2000-06       Impact factor: 1.650

4.  Glycoprotein E of varicella-zoster virus enhances cell-cell contact in polarized epithelial cells.

Authors:  C Mo; E E Schneeberger; A M Arvin
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

5.  Identification of zinc ligands of the insulin-degrading enzyme.

Authors:  R K Perlman; M R Rosner
Journal:  J Biol Chem       Date:  1994-12-30       Impact factor: 5.157

6.  Mutations in the N termini of herpes simplex virus type 1 and 2 gDs alter functional interactions with the entry/fusion receptors HVEM, nectin-2, and 3-O-sulfated heparan sulfate but not with nectin-1.

Authors:  Miri Yoon; Anna Zago; Deepak Shukla; Patricia G Spear
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

7.  Glycoprotein I of varicella-zoster virus is required for viral replication in skin and T cells.

Authors:  Jennifer Moffat; Hideki Ito; Marvin Sommer; Shannon Taylor; Ann M Arvin
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

8.  Structure-based mutagenesis of herpes simplex virus glycoprotein D defines three critical regions at the gD-HveA/HVEM binding interface.

Authors:  Sarah A Connolly; Daniel J Landsburg; Andrea Carfi; Don C Wiley; Gary H Cohen; Roselyn J Eisenberg
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

Review 9.  Membrane fusion mediated by herpesvirus glycoproteins: the paradigm of varicella-zoster virus.

Authors:  Nancy L Cole; Charles Grose
Journal:  Rev Med Virol       Date:  2003 Jul-Aug       Impact factor: 6.989

10.  The requirement of varicella zoster virus glycoprotein E (gE) for viral replication and effects of glycoprotein I on gE in melanoma cells.

Authors:  Chengjun Mo; Jay Lee; Marvin Sommer; Charles Grose; Ann M Arvin
Journal:  Virology       Date:  2002-12-20       Impact factor: 3.616

View more
  19 in total

1.  Mutagenesis of varicella-zoster virus glycoprotein I (gI) identifies a cysteine residue critical for gE/gI heterodimer formation, gI structure, and virulence in skin cells.

Authors:  Stefan L Oliver; Marvin H Sommer; Mike Reichelt; Jaya Rajamani; Leonssia Vlaycheva-Beisheim; Shaye Stamatis; Jason Cheng; Carol Jones; James Zehnder; Ann M Arvin
Journal:  J Virol       Date:  2011-02-23       Impact factor: 5.103

2.  Varicella-Zoster Virus Glycoproteins: Entry, Replication, and Pathogenesis.

Authors:  Stefan L Oliver; Edward Yang; Ann M Arvin
Journal:  Curr Clin Microbiol Rep       Date:  2016-09-09

3.  Anion activation site of insulin-degrading enzyme.

Authors:  Nicholas Noinaj; Eun Suk Song; Sonia Bhasin; Benjamin J Alper; Walter K Schmidt; Louis B Hersh; David W Rodgers
Journal:  J Biol Chem       Date:  2011-11-02       Impact factor: 5.157

4.  The insulin degrading enzyme binding domain of varicella-zoster virus (VZV) glycoprotein E is important for cell-to-cell spread and VZV infectivity, while a glycoprotein I binding domain is essential for infection.

Authors:  Mir A Ali; Qingxue Li; Elizabeth R Fischer; Jeffrey I Cohen
Journal:  Virology       Date:  2009-02-23       Impact factor: 3.616

5.  Functions of the unique N-terminal region of glycoprotein E in the pathogenesis of varicella-zoster virus infection.

Authors:  Barbara Berarducci; Jaya Rajamani; Leigh Zerboni; Xibing Che; Marvin Sommer; Ann M Arvin
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-04       Impact factor: 11.205

6.  Insulin degrading enzyme induces a conformational change in varicella-zoster virus gE, and enhances virus infectivity and stability.

Authors:  Qingxue Li; Mir A Ali; Kening Wang; Dean Sayre; Frederick G Hamel; Elizabeth R Fischer; Robert G Bennett; Jeffrey I Cohen
Journal:  PLoS One       Date:  2010-06-25       Impact factor: 3.240

Review 7.  The irreversible binding of amyloid peptide substrates to insulin-degrading enzyme: a biological perspective.

Authors:  Matías B de Tullio; Laura Morelli; Eduardo M Castaño
Journal:  Prion       Date:  2008-05-01       Impact factor: 3.931

8.  Global Mapping of O-Glycosylation of Varicella Zoster Virus, Human Cytomegalovirus, and Epstein-Barr Virus.

Authors:  Ieva Bagdonaite; Rickard Nordén; Hiren J Joshi; Sarah L King; Sergey Y Vakhrushev; Sigvard Olofsson; Hans H Wandall
Journal:  J Biol Chem       Date:  2016-04-15       Impact factor: 5.157

9.  Insulin-degrading enzyme binds to the nonglycosylated precursor of varicella-zoster virus gE protein found in the endoplasmic reticulum.

Authors:  J E Carpenter; W Jackson; G A de Souza; L Haarr; C Grose
Journal:  J Virol       Date:  2009-10-28       Impact factor: 5.103

10.  Deletion of the first cysteine-rich region of the varicella-zoster virus glycoprotein E ectodomain abolishes the gE and gI interaction and differentially affects cell-cell spread and viral entry.

Authors:  Barbara Berarducci; Jaya Rajamani; Mike Reichelt; Marvin Sommer; Leigh Zerboni; Ann M Arvin
Journal:  J Virol       Date:  2008-10-22       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.